Condition

Infertility, Female

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 23 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials23
Recruiting2
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

23 shown
Convergent Mechanisms Underlying Reprometabolic Syndrome in WomenNCT06686537 · 2025-02-25
RECRUITING
Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) CohortNCT06167135 · 2021-09-10
RECRUITING
Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOSNCT07687667 · 2026-07-01
NOT_YET_RECRUITING
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and ObesityNCT06775093 · 2025-03-01
NOT_YET_RECRUITING
Dietary Reversal of the Reprometabolic SyndromeNCT07227766 · 2024-08-10
ACTIVE_NOT_RECRUITING
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and InfertilityNCT05952882 · 2023-11-01
UNKNOWN
Assessment of the Feasibility of Frozen Embryo Transfers in a Natural Cycle Among Obese Compared to Non-Obese PatientsNCT07450300 · 2022-11-01
COMPLETED
Identifying Disease Mechanisms Underlying the Association Between Asthma and Infertility - The INFLammation Asthma Mechanism Endometrium (INFLAME) StudyNCT04626557 · 2020-11-02
UNKNOWN
The Impact of Body Mass Index on the Endometrial Microbiome in IVF Treatments. Tampere Infertility Microbiome Project (TIMP).NCT04168567 · 2020-08-14
COMPLETED
The MOM TO BE StudyNCT04273048 · 2020-07-21
TERMINATED
Internet-based Intervention to Promote a Healthy Lifestyle on the Reproductive Parameters of Overweight and Obese WomenNCT04275869 · 2020-02-27
WITHDRAWN
Turner Syndrome Minipuberty StudyNCT04189406 · 2020-02-01
UNKNOWN
Effect of Lifestyle and/or Metformin Intervention on Pregnancy Outcome, A Pilot Randomized Controlled TrialNCT03898037 · 2019-06-13
COMPLETED
Fit-for-Fertility Multicenter Randomized Controlled TrialNCT03908099 · 2019-04-03
ACTIVE_NOT_RECRUITING
3mg Liraglutide for Overweight or ObesityNCT03885297 · 2019-01-18
COMPLETED
Caloric Intake and Ovarian ReserveNCT03604770 · 2019-01-14
WITHDRAWN
Impact of Breast Cancer on Human FolliculogenesisNCT07148141 · 2019-01-11
ACTIVE_NOT_RECRUITING
Treatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study.NCT03727971 · 2019-01-01
COMPLETED
Transvaginal Ultrasonography Guided Embryo TransferNCT03473028 · 2018-04-01
COMPLETED
Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained InfertilityNCT02432209 · 2015-08-01
COMPLETED
The Effect of a Liraglutide on IVF in Obese PCOSNCT03353948 · 2014-09-01
COMPLETED
Improved Fertility After Exercise in Overweight/Obese WomenNCT01933633 · 2013-09-01
TERMINATED
Mediators of Abnormal Reproductive Function in Obesity (MARO)NCT01817400 · 2013-03-01
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED9
ACTIVE_NOT_RECRUITING3
UNKNOWN3
NOT_YET_RECRUITING2
RECRUITING2
TERMINATED2
WITHDRAWN2

Phase mix

NA9
PHASE22
PHASE32
EARLY_PHASE11
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.